248 related articles for article (PubMed ID: 14668592)
41. Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.
Satoh T; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Itoh K; Sakuma S; Takagi H
Jpn J Cancer Res; 1992 Apr; 83(4):379-86. PubMed ID: 1506272
[TBL] [Abstract][Full Text] [Related]
42. [Probe-guided surgery of colorectal carcinoma].
Lechner P
Acta Med Austriaca; 1997; 24(2):68-72. PubMed ID: 9273809
[TBL] [Abstract][Full Text] [Related]
43. Radioimmunoguided surgery: a new intraoperative approach to the detection of tumor.
Martin EW; Hinkle G; Mojzisik C; Thurston MO
Cancer Treat Res; 1990; 51():387-411. PubMed ID: 1977457
[No Abstract] [Full Text] [Related]
44. Role of tumor-associated antigen expression in radioimmunoguided surgery for colorectal and breast cancer.
Bertoglio S; Percivale P; Schenone F; Peressini A; Murolo C; Badellino F
Semin Surg Oncol; 1998 Dec; 15(4):249-53. PubMed ID: 9829382
[TBL] [Abstract][Full Text] [Related]
45. Role of radioimmunoguided surgery using iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery.
Lucisano E; Bertoglio S
Semin Surg Oncol; 1998 Dec; 15(4):212-4. PubMed ID: 9829373
[TBL] [Abstract][Full Text] [Related]
46. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
47. Radioimmunoguided surgery with different iodine-125 radiolabeled monoclonal antibodies in recurrent colorectal cancer.
Percivale P; Bertoglio S; Meszaros P; Schenone F; Gipponi M; Moresco L; Cosso M; Badellino F
Semin Surg Oncol; 1998 Dec; 15(4):231-4. PubMed ID: 9829378
[TBL] [Abstract][Full Text] [Related]
48. Radioimmunoguided surgery: clinical experience with different monoclonal antibodies and methods.
Di Carlo V; Stella M; De Nardi P; Fazio F
Tumori; 1995; 81(3 Suppl):98-102. PubMed ID: 7571064
[TBL] [Abstract][Full Text] [Related]
49. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
50. [A clinical trial of radioimmunoguided surgery for gastric cancer].
Liu BG; Xu GW; Zhang MY
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):284-7. PubMed ID: 7805559
[TBL] [Abstract][Full Text] [Related]
51. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody.
Arnold MW; Schneebaum S; Berens A; Petty L; Mojzisik C; Hinkle G; Martin EW
Ann Surg; 1992 Dec; 216(6):627-32. PubMed ID: 1466615
[TBL] [Abstract][Full Text] [Related]
52. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
[TBL] [Abstract][Full Text] [Related]
53. Radioimmunoguided surgery for colorectal carcinoma.
Filez L; Penninckx F; Ectors N; Van Cutsem E; Geboes K; Aerts R; D'Hoore A; Kerremans R
Hepatogastroenterology; 1999; 46(26):691-700. PubMed ID: 10370597
[No Abstract] [Full Text] [Related]
54. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
[TBL] [Abstract][Full Text] [Related]
55. Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.
Boxer G; Stuart-Smith S; Flynn A; Green A; Begent R
Br J Cancer; 1999 May; 80(5-6):922-6. PubMed ID: 10360677
[TBL] [Abstract][Full Text] [Related]
56. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
57. Extraction and analysis of carcinoembryonic antigen in lymph nodes: a new approach to the diagnosis of lymph node metastasis of colorectal cancer.
Kanoh T; Monden T; Tamaki Y; Ohnishi T; Ikeda K; Izawa H; Sekimoto M; Tomita N; Monden M
Dis Colon Rectum; 2002 Jun; 45(6):757-63. PubMed ID: 12072627
[TBL] [Abstract][Full Text] [Related]
58. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
Yao YF; Yang Z; Li ZF; Gu J
World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
[TBL] [Abstract][Full Text] [Related]
59. Radioimmunoguided surgery and colorectal cancer.
Aftab F; Stoldt HS; Testori A; Imperatori A; Chinol M; Paganelli G; Geraghty J
Eur J Surg Oncol; 1996 Aug; 22(4):381-8. PubMed ID: 8783657
[TBL] [Abstract][Full Text] [Related]
60. Radioimmunoassisted follow-up and surgery vs traditional examinations and surgery after radical excision of colorectal cancer.
Prati U; Roveda L; Cantoni A; Saponaro R; Bosi F; Sandolo R; Zonta A
Anticancer Res; 1995; 15(3):1081-5. PubMed ID: 7645930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
